REG - Eco Animal Health Gp - R&D Day

ECO Animal HealthAnnouncement

13/03/2025 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250313:nRSM4590Aa&default-theme=true

RNS Number : 4590A  Eco Animal Health Group PLC  13 March 2025

13 March 2025

 

 

 

ECO Animal Health Group plc

("ECO" or the "Company")

 

R&D Day

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health
company with a portfolio of marketed veterinary products and a maturing
proprietary R&D pipeline, announces that it is hosting an R&D Day
today for institutional and private investors and analysts, with
presentations starting at 2:00pm GMT at Andaz London, 40 Liverpool
St, London EC2M 7QN.

The event will be led by David Hallas, CEO, and Chris Wilks, CFO, alongside
senior leaders from across the Company and an industry expert. Attendees will
have the opportunity to gain valuable insights on how the next generation of
assets in ECO's R&D pipeline are driving long-term value creation and
future proofing the business through innovations in preventative animal
health.

For those who would like to join virtually, please register via the dedicated
registration page:
https://www.equitydevelopment.co.uk/news-and-events/eah-rd-investor-presentation-13march2025
(https://www.equitydevelopment.co.uk/news-and-events/eah-rd-investor-presentation-13march2025)
.

No new information will be provided on current trading at the R&D Day. For
guidance on FY25 trading, the Company asks investors to review the outlook
section of the interim results announced on 28 November 2024 as this remains
relevant. The Company will provide a trading update for the year ending 31
March 2025 in April 2025.

 

Following the event, slides and a recording will be made available for viewing
on the Investors section of the Company's website.

 

 

 

-Ends-

For further information please contact:

 ECO Animal Health Group plc                                    020 8447 8899

 David Hallas (CEO)

 Christopher Wilks (CFO)
 Singer Capital Markets (Nominated Adviser & Joint Broker)      020 7496 3000

 Phil Davies

 Sam Butcher
 Investec (Joint Broker)                                        020 7597 5970

 Gary Clarence

 Lydia Zychowska
 Equity Development                                             020 7065 2692

 Hannah Crowe

 Matt Evans
 ICR Healthcare (Financial PR)                                  020 3709 5700

 Mary-Jane Elliott                                              ecoanimalhealth@consilium-comms.com

 Jessica Hodgson

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing
branded veterinary pharmaceuticals globally, with expertise in antibiotics and
vaccines for pigs and poultry. We have a maturing proprietary R&D
pipeline.

Headquartered in the UK, with global offices including R&D and
manufacturing, we have marketing authorisations in over 70 countries and
employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is
effective against both respiratory and intestinal diseases in pigs and
poultry.

Click here for more information: https://ecoanimalhealth.com
(https://ecoanimalhealth.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCKZGMFLZLGKZM